Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 17   

Articles published

ENZN 1.08 -0.02 (-1.82%)
price chart
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
This is a signal of significant strength within the corporation. Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and ...
Enzon Pharmaceuticals Upgraded to �Hold� at TheStreet (ENZN)
Enzon Pharmaceuticals Inc. logo Enzon Pharmaceuticals (NASDAQ:ENZN) was upgraded by investment analysts at TheStreet from a �sell� rating to a �hold� rating in a note issued to investors on Tuesday.
Investor's Watch List - Enzon Pharmaceuticals Inc (ENZN), Violin Memory Inc ...
Birmingham, West Midlands - (TechSonian) - June 30, 2014 - Enzon Pharmaceuticals Inc (NASDAQ:ENZN) is involved in licensing drug products.
Related articles »  
Enzon Pharmaceuticals Rating Increased to Hold at TheStreet (ENZN)
Enzon Pharmaceuticals Inc. logo TheStreet upgraded shares of Enzon Pharmaceuticals (NASDAQ:ENZN) from a sell rating to a hold rating in a research note issued to investors on Tuesday.
Enzon Pharmaceuticals Stock Rating Upgraded by TheStreet (ENZN)
Enzon Pharmaceuticals Inc. logo Enzon Pharmaceuticals (NASDAQ:ENZN) was upgraded by TheStreet from a �sell� rating to a �hold� rating in a research note issued on Tuesday.
Related articles »  
Healthcare Losers: Enzon Pharmaceuticals Inc (NASDAQ:ENZN), IGI ...
On June 10, 2014, Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) received a letter from the Listing Qualifications staff of The NASDAQ Stock Market LLC (�Nasdaq�) indicating that, based upon the closing bid price of the Company's common stock for the last ...
Related articles »  
Healthcare Volatile Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) on June 25 received a letter from the Listing Qualifications staff of The NASDAQ Stock Market indicating that the Nasdaq Staff has determined that for the last 10 consecutive business days, from June 10 to June ...
Related articles »  
Trader's Buzzers�Iridium Communications (NASDAQGS:IRDM), Enzon ...
Enzon Pharmaceuticals Inc. (ENZN)is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn's disease; ...
Stocks Alert: Gilead Sciences Inc. (NASDAQ:GILD), Ariad Pharmaceuticals Inc ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN)'s shares dropped 2.73% to $1.07. ENZN's stock was upgraded by investment analysts at TheStreet from a �sell� rating to a �hold� rating in a note issued to investors on July 8. The analysts wrote, �Enzon ...
Stocks Buzz- Profire Energy, Inc. (NASDAQ:PFIE), Enzon Pharmaceuticals ...
Las Vegas, NV - July 01, 2014� (TechSonian) - Profire Energy, Inc. (NASDAQ:PFIE)declared the pricing of a $24,000,000 underwritten public offering of 6,000,000 shares of its common stock, at a price of $4.00 per share.
Related articles »